Changde BKMAM Biotechnology Co., Ltd.

Changde BKMAM Biotechnology Co., Ltd. specializes in centrifuge tubes for in vitro diagnostic (IVD) use. These devices are designed for laboratory applications, such as processing and separating biological samples like blood or tissue. The focus is on Class I medical devices, which are generally considered low-risk and do not require pre-market approval but must still comply with regulatory requirements.

The company is based in the United States, which means its devices are subject to FDA regulations. Since its products fall under Class I classification, they are exempt from pre-market approval but must still meet FDA requirements for labeling, manufacturing practices, and reporting. The FDA’s Unique Device Identifier (UDI) database includes its listed devices, ensuring traceability and transparency in the regulatory system.

Changde BKMAM Biotechnology Co., Ltd.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is used to track medical devices in the U.S. market, ensuring compliance with identification and reporting standards. Listing in the UDI database is mandatory for Class I devices to facilitate regulatory oversight and market surveillance.

The company’s devices are classified as Class I medical devices under FDA regulations. This classification applies to products that pose minimal risk to patients and users, such as certain diagnostic accessories like centrifuge tubes. Class I devices typically require compliance with general controls (e.g., labeling, manufacturing practices) but do not undergo pre-market review unless they involve new technologies or higher risks.